Nature Cell, an international leader in stem cell products, is opening a manufacturing facility in the Baltimore City complex Gaslight Square.
The 100,000 sq. ft. facility will allow the company to grow its stem cell therapy research and development, with hopes to produce one million doses of its product JointStem, an intra-articular stem cell injection, per year.
“We have chosen Maryland for the site of the Nature Cell Biostar USA Stem Cell Campus after a comprehensive evaluation of the state’s exceptional ecosystem for our business,” said Nature Cell Chairman Dr. Jeong-Chan Ra. “Maryland offers an abundant pool of highly-skilled technical talent that is critical to establishing global leadership and setting industry standards in stem cell therapeutics.”
The Maryland Stem Cell Research Fund and the state’s life sciences workforce were key factors for the company selecting Maryland and Baltimore City for this new location. Nature Cell estimates creating 500 new full-time jobs at the facility over the next six years.
“The State of Maryland and Baltimore City also provide strong business support, including dedicated engagement from their government teams,” Dr. Ra continued. “Additionally, the region’s highly collaborative industry and academic network, anchored by world-class institutions such as Johns Hopkins University School of Medicine and its affiliated hospitals, are central to advancing stem cell research and development.”
